<code id='CC623AFCA6'></code><style id='CC623AFCA6'></style>
    • <acronym id='CC623AFCA6'></acronym>
      <center id='CC623AFCA6'><center id='CC623AFCA6'><tfoot id='CC623AFCA6'></tfoot></center><abbr id='CC623AFCA6'><dir id='CC623AFCA6'><tfoot id='CC623AFCA6'></tfoot><noframes id='CC623AFCA6'>

    • <optgroup id='CC623AFCA6'><strike id='CC623AFCA6'><sup id='CC623AFCA6'></sup></strike><code id='CC623AFCA6'></code></optgroup>
        1. <b id='CC623AFCA6'><label id='CC623AFCA6'><select id='CC623AFCA6'><dt id='CC623AFCA6'><span id='CC623AFCA6'></span></dt></select></label></b><u id='CC623AFCA6'></u>
          <i id='CC623AFCA6'><strike id='CC623AFCA6'><tt id='CC623AFCA6'><pre id='CC623AFCA6'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:1
          Humana sign -- health business coverage from STAT
          Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

          Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

          The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

          advertisement

          The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          Crinetics acromegaly drug succeeds in late
          Crinetics acromegaly drug succeeds in late

          AresearcherworkinginthelabatCrineticsPharmaceuticalsinSanDiego.CourtesyCrineticsSANDIEGO—CrineticsPh

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

          AllenG.Breed/APNewbiotechnewsletterlaunchingthisThursday.Don’tmissout.Heythere.Today,wediscusstheimp